Physician profile
Paul Hicks
NPI 1255366217
$3,046.64
in general payments reported to CMS, 2019-2025
16 companies · $24.98 in 2025
The $24.98 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $15.48 · 2021: $87.10 · 2022: $184 · 2023: $2,211 · 2024: $24.14 · 2025: $24.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,544 · Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,543.89 |
| Food and Beverage | $715.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,162.78 | 2022-2023 | Watchman Access System |
| Biotronik INC. | $346.57 | 2019-2023 | Acticor 7 Vr-T Dx, Biomonitor |
| Kestra Medical Technology Services, INC. | $149.68 | 2022-2025 | Assure Wcd |
| Amgen INC. | $82.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.66 | 2019 | |
| Vifor Pharma, INC. | $40.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.85 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $34.73 | 2019-2021 | |
| Edwards Lifesciences Corporation | $29.54 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.50 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $22.90 | 2023 | Arcalyst |
| Philips North America LLC | $18.81 | 2019 | |
| Abiomed | $15.48 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.66 | 2019 | |
| Amarin Pharma, INC. | $12.65 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.